Exploring dynamics and strategies of niche protection

被引:43
作者
Boon, Wouter P. C. [1 ]
Moors, Ellen H. M. [1 ]
Meijer, Albert J. [2 ]
机构
[1] Univ Utrecht, Copernicus Inst Sustainable Dev, NL-3584 CS Utrecht, Netherlands
[2] Univ Utrecht, Utrecht Sch Governance, NL-3511 ZC Utrecht, Netherlands
关键词
Protective space; Niche; Narratives; Fast access to innovations; Pharmaceutical sector; NURTURED NICHES; TECHNO THERAPY; NETHERLANDS; POLICY; SUSTAINABILITY; MANAGEMENT; SOCIOLOGY; REGIME; DRUGS;
D O I
10.1016/j.respol.2014.01.005
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
This paper focuses on the processes and strategies of advocates and opponents in creating, maintaining and/or contesting the protective spaces in which 'urgently needed' but 'risky' pharmaceutical innovations are managed. Drawing on transition literature and recent work on niche protection, this paper adds to the conceptualisation and empirical grounding of niche protection by studying the dynamics of protection, in particular the different phases of niche development. Moreover, the links between niche protection processes and protection strategies pursued by niche players are explored. Dynamics of niche protection are explored in two case studies: the monitoring of treatments for HIV and of a vaccination against pandemic influenza. We conclude that niche protection depends on interactions between network building, empowerment activities and the construction of a positive niche narrative vis-a-vis anti-narratives raised by actors outside the niche. Furthermore, the nature of learning within a niche and the niche's robustness are determined by whether the strategies are predominantly accommodating or restrictive. (C) 2014 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:792 / 803
页数:12
相关论文
共 40 条
[1]  
[Anonymous], EXPERIMENTING FOR SU
[2]   Exploring emerging technologies using metaphors - A study of orphan drugs and pharmacogenomics [J].
Boon, Wouter ;
Moors, Ellen .
SOCIAL SCIENCE & MEDICINE, 2008, 66 (09) :1915-1927
[3]   The sociology of expectations in science and technology [J].
Borup, Mads ;
Brown, Nik ;
Konrad, Kornelia ;
Van Lente, Harro .
TECHNOLOGY ANALYSIS & STRATEGIC MANAGEMENT, 2006, 18 (3-4) :285-298
[4]   Adverse drug reaction reporting by patients in the Netherlands - Three years of experience [J].
de Langen, Joyce ;
van Hunsel, Florence ;
Passier, Anneke ;
de Jong-van den Berg, Lolkje ;
van Grootheest, Kees .
DRUG SAFETY, 2008, 31 (06) :515-524
[5]  
De Mooij A., 2004, GEEN PANIEKL AIDS IN
[6]   Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma [J].
Eichler, Hans-Georg ;
Pignatti, Francesco ;
Flamion, Bruno ;
Leufkens, Hubert ;
Breckenridge, Alasdair .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (10) :818-826
[7]   BUILDING THEORIES FROM CASE-STUDY RESEARCH [J].
EISENHARDT, KM .
ACADEMY OF MANAGEMENT REVIEW, 1989, 14 (04) :532-550
[8]  
EMA, 2010, THE EUROPEAN MEDICIN
[9]  
EMEA, 2004, COMMITTEE FOR PROPRI
[10]   Activism, drug regulation, and the politics of therapeutic evaluation in the AIDS era: A case study of ddC and the 'surrogate markers' debate [J].
Epstein, S .
SOCIAL STUDIES OF SCIENCE, 1997, 27 (05) :691-726